Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Where are the "under .04 by September 1"
Didn't the share price get down to like .0485 or at least in the .05's? That is pretty darn close so I wouldn't toot my horn too much.
I'm sorry Maple, but you will need to go to the other board if you want to buy shares. This board is for us malcontents, disgruntled shareholders and shorts. LOL, of course, I'm kidding but some make it out to be that way.
This happens to a lot of shareholders, past and present, after they become disillusioned with the elusive PR's, non-audited financials, lack of promised follow-up, lack of guidance achievement, 10Q's/10K's that don't properly add, lack of any profitable business model in 15 years of business, shady characters constantly circling around, insiders who constantly demonize shareholders, etc. But, hey, what's not to like.
Click on the submission number and drill down under eDossier. You will see a number of filings and acceptance right at the end of October
I don't think it caught anyone off guard. The post is no more believable or verifiable than one of Berman's elusive PR's. But, I do have to admit, it will serve as interesting debate once the quarterly is published.
GBLX quarterly should have ended 9/30/17. I think we should see an earnings report by mid November.
My thought is that big pharma will eventually help to get cannabis listed as schedule III which I believe would make it legal for prescriptions at the fed level. They would then go all in with research at the medicinal level to increase their footprint. I think they are smart enough to see the writing on the wall and will work like hell to control it so that they can make a lot of money.
Thanks for the clarification Super!
They must be able to sell to Louisiana because they have contracts with a couple universities there.
Yes, but Berman's sole interest in Taug at the time was to merge into a shell in order to clean up his financial reporting mess. I think everyone realized that Taug was a shell only. This, however, doesn't necessarily paint DECN as some holier than thou pinky who resides on higher moral ground. I, for one, certainly don't believe DECN's financials at all. There are so many errors in them and they are filled with redundant junk that I personally think most of it is just made up and they have very little sales. All in my opinion of course...
oh, believe me, I agree. I was just stating were the quote came from. I invested in this company years ago and will never put another dime in it because I don't trust management. They have been doing the same schtick the entire time I have been aware of their existence. And, almost always, there is a new set of investors that comes along and thinks they have found the fountain of youth that will make them rich.
Well, hopefully people don't have their life savings in a penny stock. Now, that would be a disaster. Speculation is one thing. Investing your retirement in a non-reporting penny stock is definitely something else.
Scoop, Zoran was quoting me based on a response I had about some shareholders average SP being $1.30.
This is classic P&D scheme. Cronies buy stock when there is no news. Company releases PR's and cronies sell into the news while the average stockholder is behind the curve trying to get in on the action. By the time they realize it, the momo is done and the people who make money are out. Ba Da Bing, Ba Da Boom! A new set of bag holders! and, of course, a few longs who just cant see the horizon.
Dang pescelepesce! I have to admit I literally laughed out loud at your post.
DECN Proforma financials = Caveman math on the back of a napkin and a mustard stain on Bermans shirt from the diner
I'm not even convinced that the margins are really all that great.
I can tell you though, even before Berman stopped producing audited financials it was a merry go round with CPA firms. Berman always tried to make it look like it was the CPA's fault for their break ups with his cryptic doublespeak but, I suspect those CPA firms were reluctant to sign their name to anything he produced for fear of sanctions for sketchy financials.
The results speak for themselves. This whole "they wont give me back my homework" story is a bunch of malarkey. Don't you think Berman could have gotten audited financials by now if he had the goods? He hasn't produced audited financials in years. And, if it was because his last CPA didn't give him back his paperwork then why hasn't he produced audited financials since then with the information that he does have in subsequent years? Hmmmmmmmm.
LOL, my words are not nearly as eloquent as yours but, yes, that is his method.
And, Honestly, who in the their right mind would give a company like this 6 million dollars without audited financials. I work for a 100 million dollar company and anyone giving us a loan would require audited financials.
This will be Berman's opportunity to write off debt, money and blame everything on JJ delaying his business model until lo a behold a new technology gets approved in the USA. The last time KB changed business models he wrote off millions in receivables that I suspect never existed and is one of the reasons he cant get audited financials. NO CPA with a shred of integrity would put his name to DECN's financials.
Published October 6, 2017 by Joseph Gustaitis
Print Text Size: A A A
Many people with diabetes want to test their blood sugar levels regularly but don’t. The reason that most of them give is that they just don’t want to go through the unpleasant business of sticking their finger to draw blood. However, the U.S. Food and Drug Administration (FDA) has just approved a new technology that its manufacturer advertises as a breakthrough that “eliminates the need for routine fingersticks.”
The device is called the FreeStyle Libre Flash Glucose Monitoring System (FreeStyle Libre for short), and it’s the creation of Abbott, a global health-care company based in Illinois. The system checks blood glucose levels through a sensor that’s about the size of two stacked quarters. The user applies the waterproof sensor to the back of the upper arm. Once it’s in place, the user is able to scan it with a small handheld reader. The scan is painless and takes about a second. Because the scanner can make readings through clothing, the wearer doesn’t have to uncover the upper arm to get a reading.
Advertisement
.
The scan identifies glucose levels as high, low, or stable and provides an 8-hour history of fluctuations — in other words, the FreeStyle Libre essentially works as a continuous glucose monitor (CGM). The manufacturer says that the FreeStyle Libre is calibrated at the factory and therefore doesn’t require daily calibration by the user through fingersticks, as some other CGMs do. The device is especially recommended for people being treated with insulin, because these are the ones who require the most careful and frequent monitoring.
Although it has just been approved in the United States, the FreeStyle Libre has already been used by more than 400,000 people in about 40 countries. The manufacturer says reports indicate that users test their glucose levels at an average of at least 15 times a day, a frequency that leads to better overall glucose control. Abbott expects that the device will be available at U.S. pharmacies before the end of the year. To get one, a user will need a doctor’s prescription
I can confirm the entries that Loan is talking about. I went to the blog right after he posted it and there was most definitely a reference to KB. Now that its gone it is even more suspicious.
The answer is "Plausible Deniability". Berman and his people will use the ambiguous language to form their narrative if and when it is questioned. In the mean time, he is trying to appear he is in control. Unfortunately, there is nothing to control really. The company barely does any business and the lawyers are in control of the J&J lawsuit. I am not convinced at all that the financials are even remotely legit and this is why Berman cant get them audited. Every statement he makes is a distraction.
For Gods sakes....
"Accurate, non-invasive glucose monitoring integrated to smart phone / wifi technology will be the future. DECN needs to establish itself as a leader NOW to fund development later for such technology (which is already under development and supported by the healthcare system in the UK). The third world countries will lag behind the new technology due to price and still be a viable market for what will be legacy test strips"
Please don't give Berman any ideas that could run shareholders down another never ending rabbit hole of splits and giggles and massive share dilution.
Assuming one had purchased 100,000 shares that long ago their share count would now be at 89.29 shares adjusting for both stock splits with a value of $5.36 at todays current price. 1 million shares purchased that long ago would have a value of $53.58. Nice job Berman!
Are you serious? To my knowledge diabetics have to be tested several times a day or more. Cant be running down to the neighborhood clinic every few hours to get a test.
@aol.com
AOL? really? LOL, Who uses AOL anymore? This guys a real lawyer?
Maybe Berman taught Taug. Berman did do a 1-80 and a 1-14 reverse split after all wiping out a bunch of shareholders. If you reverse those splits what would be the total of shares outstanding for DECN?
total hogwash explanation. I sure hope DECN has their balance sheet audited. I would like to know if these transactions are really even occurring. I, like Loan, have a hard time believing someone is paying market rate much less a premium for such a lofty investment. In fact, I cant remember ever seeing a share placement like this not being transacted at a discount.
"We currently maintain an executive office at 2660 Townsgate Road, Suite 300, Westlake Village, CA 91361. The space consists of approximately 2,300 square feet. The monthly rental for the space is $2,170 per month on a month-to-month basis. We also maintain space in a public warehouse in Miami, FL, and pay for space indirectly in York, PA for the completion of necessary clinical trials."
I love how the statement goes into detail regarding square footage of the CA space and its cost and then fades to blackness regarding the FL warehouse. What? do they have a kiosk down there?
"Please provide articles, filings and/or links that support the point that the CEO is lying and deceiving."
Here ya go Pluto:
http://www.decisiondiagnostics.co/
Yes, the redundancy in reports is ridiculous. In addition, Berman just adds on to each quarterly narrative with a few repetitive updates so it gets longer and longer each time.
You would have thought Berman would have been smart enough to at least change the financing number for this repeat performance. But, no, he was too lazy to even do that.
Z, I hope you don't have a ton of money invested here. You are going to lose like just about every other investor that has invested in this company, including myself. Thank God I wasn't stupid enough to invest very much in this loser.
Baseless accusations? I have personally witnessed these same scenarios being played by Berman over and over without any, and I mean none, facts like the actual company making an offer or what the actual offer price is or ever was. And, what makes you think I haven't reported this company to the SEC?
What does that have to do with it? Even if they don't, they did at one time and I will bet that they lost money. Believe me, they have reason to be upset.
Its not crazy cheap. Its worthless. There is no true offer on the table. This is the repeat part of wash, rinse and repeat. Berman and the ghost board will reject the offer saying it was deemed undervalued and not in the best interest of shareholders.
You people who think you have found the next great penny stock company are in for a rude but predictable awakening. You should listen to the likes of KSviking and Cakes. They have been around, know the game and have seen the light.
The 56 million number is hogwash. This is the same number that was bantered around years ago long before GenUltimate!, GenSure! and GenChoice! were even a pipe dream of Bermans. This was the number used to speculate 1 year of financing for Genstrip. The anticipation was that DECN would be able to roll this financing over and over to fund the cost of production, marketing and sales. as you can see it never happened.
Decision Diagnostics Board Reacts Positively to Above-Market Offer....
LOL, what, did Berman raise an eyebrow? Was that the positive reaction?
I have seen this scenario several times with this company and I doubt the outcome will be any different than the last ones.
So, pluto, are you saying that the FDA is going to implement these standards in Sept.? Cuz they are the only entity that really matters when it comes to US regulations